Boulder, Colorado
United States
37
2026-05-28
14
2025-08-12
These are the the leading inventors for applications assigned to SomaLogic Operating Co., Inc.:
SomaLogic Operating Co., Inc. based in Boulder, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Controlling Intersample Analyte Variability in Complex Biological Matrices
#2 | 2025-10-16Click-Labeled Nucleosides and Phosphoramidites
#3 | 2025-09-11Modified Nucleosides
#4 | 2025-08-12 ✅ Patent 12,383,878 granted on 2025-08-12Systems and methods for monitoring orbital shaker health
#5 | 2025-07-17Methods for Sample Quality Assessment
#6 | 2025-06-26Methods for Sample Quality Assessment
#7 | 2025-06-05Methods for Sample Quality Assessment
#8 | 2025-05-08Multiplexed Analyses of Test Samples
#9 | 2025-04-24Oligonucleotides Comprising Modified Nucleosides
#10 | 2025-03-20Methods for Sample Quality Assessment
#11 | 2025-03-20Methods of Solid-Phase Nucleic Acid Hybridization
#12 | 2025-02-13Methods for Sample Quality Assessment
#13 | 2024-11-28Lung Cancer Prediction and Uses Thereof
#14 | 2024-11-19 ✅ Patent 12,145,154 granted on 2024-11-19Assay array plate
#15 | 2024-11-05 ✅ Patent 12,134,798 granted on 2024-11-05Methods of detecting a leak from a subarray of a microarray chip, kits of components that facilitate leak detection, and microarray chips configured for leak detection
#16 | 2024-08-01Renal Insufficiency Prediction and Uses Thereof
#17 | 2024-07-18 ✅ Patent 12,498,365 granted on 2025-12-16NEXT-GENERATION SEQUENCING FOR PROTEIN MEASUREMENT
#18 | 2024-07-04Nucleic Acid Compounds That Bind Coronavirus Proteins
#19 | 2024-04-25Spin-Labeled Nucleosides and Phosphoramidites
#20 | 2024-03-21Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof
#21 | 2023-12-07Cardiovascular Event Risk Prediction
#22 | 2023-11-02 ✅ Patent 12,241,896 granted on 2025-03-04Proteomic assay using quantum sensors
#23 | 2023-10-05 ✅ Patent 12,180,482 granted on 2024-12-31Oligonucleotides comprising modified nucleosides
#24 | 2023-07-06 ✅ Patent 11,965,880 granted on 2024-04-23Next-generation sequencing for protein measurement
#25 | 2023-06-22Nucleic Acid Compounds for Binding Growth Differentiation Factor 11
#26 | 2023-06-22 ✅ Patent 12,064,769 granted on 2024-08-20Method for conducting uniform reactions
#27 | 2023-03-23Nucleic Acid Compounds for Binding to Complement Component 3 Protein
#28 | 2023-03-09Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof
#29 | 2023-02-16Methods of Determining Impaired Glucose Tolerance
#30 | 2022-11-03Cardiovascular Risk Event Prediction and Uses Thereof
#31 | 2022-10-20Nucleic Acid Compounds that Bind to Retinoic Acid-Inducible Gene I Protein
#32 | 2022-08-18 ✅ Patent 12,480,956 granted on 2025-11-25Controlling Intersample Analyte Variability in Complex Biological Matrices
#33 | 2022-06-02 ✅ Patent 11,698,373 granted on 2023-07-11Proteomic assay using quantum sensors
#34 | 2022-03-24 ✅ Patent 12,098,370 granted on 2024-09-24Method for generating aptamers with improved off-rates
#35 | 2021-06-10 ✅ Patent 11,578,330 granted on 2023-02-14Oligonucleotides comprising modified nucleosides
#36 | 2021-05-06 ✅ Patent 11,535,852 granted on 2022-12-27Nucleic acid compounds for binding growth differentiation factor 11
#37 | 2017-06-15 ✅ Patent 11,466,275 granted on 2022-10-11Nucleic acid compounds for binding to complement component 3 protein
Also check out SomaLogic Operating Co., Inc.'s (Boulder, United States) applicant profile with 36 patent applications submitted.
327317 ⎘